Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Collaboration › Details

Seagen–JPMorgan Chase: investor conference, 202101 supply service Seagen presents at JP Morgan Healthcare Conference 2021


Period Period 2021-01-11
Organisations Partner, 1st Seagen Inc. (Nasdaq: SGEN)
  Group Seagen (Group)
  Partner, 2nd J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL
  Product 2 biopharmaceutical

Seagen Inc.. (12/16/20). "Press Release: Seagen to Present at the J.P. Morgan Healthcare Conference". Bothell, WA.

Seagen Inc. (Nasdaq: SGEN) today announced that management will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 2:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from Seagen’s website at in the Investors section.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit and follow @SeagenGlobal on Twitter.

Peggy Pinkston
(425) 527-4160

Record changed: 2020-12-17


Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

More documents for Seagen (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

» top